The Radiosensitizing Potentials of Silymarin/Silibinin in Cancer: A Systematic Review.
Jitendra GuptaAbduladheem Turki JalilZainab Al-Hawraa Riyad MuediiZafar AminovFahad AlsaikhanAndrés Ramírez-CoronelPushpamala RamaiahBagher FarhoodPublished in: Current medicinal chemistry (2023)
In most cases, silymarin/silibinin administration could sensitize the cancer cells to ionizing radiation through an increase of free radical formation, induction of DNA damage, increase of apoptosis, inhibition of angiogenesis and metastasis, etc. However, suggesting the use of silymarin/silibinin during radiotherapeutic treatment of cancer patients requires further clinical studies.